▶ 調査レポート

OTCコンシューマーヘルスケアの世界市場

• 英文タイトル:Global Market Study on OTC Consumer Healthcare: Increasing Sales of Analgesics Contributing to Market Growth

Persistence Market Researchが調査・発行した産業分析レポートです。OTCコンシューマーヘルスケアの世界市場 / Global Market Study on OTC Consumer Healthcare: Increasing Sales of Analgesics Contributing to Market Growth / PMR2008013資料のイメージです。• レポートコード:PMR2008013
• 出版社/出版日:Persistence Market Research / 2020年7月31日
• レポート形態:英文、PDF、300ページ
• 納品方法:Eメール
• 産業分類:消費財
• 販売価格(消費税別)
  Individual User(1名用)¥524,300 (USD4,900)▷ お問い合わせ
  Multi User(5名用)¥813,200 (USD7,600)▷ お問い合わせ
  Corporate User(企業用)¥1,134,200 (USD10,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、OTCコンシューマーヘルスケアの世界市場について調査・分析し、エグゼクティブサマリー、市場概要、主要市場動向、市場におけるリスク・機会、新型コロナウイルスの市場への影響、新型コロナウイルスのOTCコンシューマーヘルスケア市場への影響、新型コロナウイルスの小売業への影響、需要分析・予測、価格分析、市場背景、製品別(OTC医薬品、ダイエットサプリメント)分析、エンドユーザー別(12-19歳、男性、女性、キッズ)分析、フォームタイプ別(タブレット、粉末、液体、その他)分析、販売経路別(卸売業者・販売業者、薬局/ドラッグストア、専門店、オンライン小売業者、ハイパーマーケット/スーパーマーケット)分析、地域別分析、市場構造分析、競争分析、仮定、調査手法などを含め、以下の構成でお届けいたします。
・エグゼクティブサマリー
・市場概要
・主要市場動向
・市場におけるリスク・機会
・新型コロナウイルスの市場への影響
・新型コロナウイルスのOTCコンシューマーヘルスケア市場への影響
・新型コロナウイルスの小売業への影響
・需要分析・予測
・価格分析
・市場背景
・OTCコンシューマーヘルスケアの世界市場規模:製品別(OTC医薬品、ダイエットサプリメント)
・OTCコンシューマーヘルスケアの世界市場規模:エンドユーザー別(12-19歳、男性、女性、キッズ)
・OTCコンシューマーヘルスケアの世界市場規模:フォームタイプ別(タブレット、粉末、液体、その他)
・OTCコンシューマーヘルスケアの世界市場規模:販売経路別(卸売業者・販売業者、薬局/ドラッグストア、専門店、オンライン小売業者、ハイパーマーケット/スーパーマーケット)
・OTCコンシューマーヘルスケアの世界市場規模:地域別
・市場構造分析
・競争分析
・仮定
・調査手法

Persistence Market Research (PMR) has recently published a new research analysis on the OTC consumer healthcare market for the assessment period of 2020-2030. The research study offers a close look at the evolving aspects of the OTC consumer healthcare market and the dynamics impacting market growth. It also focuses on key developments that have made a mark in the OTC consumer healthcare market, and what other developments are on the cards. The report talks about various macro- and micro-economic factors responsible for giving an in-depth analysis of the market.

The research study on the OTC consumer healthcare market extensively focuses on key trends shaping its growth. In addition, opportunity analysis on OTC consumer healthcare underline untapped corners for aspiring players to make a note of. In addition, this research study on the OTC consumer healthcare market also offers a panoramic view of the incremental opportunity, which can further help readers make well-informed decisions.

Several stakeholders in the OTC consumer healthcare market can rely on the data offered in this research study and delve into pragmatic decision-making. Moreover, information offered in the report also can help new market entrants expand their bases in the OTC consumer healthcare market.

The report elaborates on both, historical and current trends molding the growth of the OTC consumer healthcare market. The performance of the OTC consumer healthcare market has been drawn and analyzed in ways that the lucrative side of the market is evident to readers. Competitive landscape provided in the report gives a detailed outlook of the profiles of key companies operating in the market, along with their differential strategies and key focus areas.

レポート目次

1. Executive Summary

1.1. Global Market Outlook

1.2. Summary of Key Statistics

1.3. Summary of Key Findings

1.4. Product Evolution Analysis

1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Taxonomy

2.2. Market Definition

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.1.1. The Entrance of New Brands Aggravates Competition

3.1.2. People have now switched to self-treatment

3.1.3. Analgesics to Continue Dominating the Market in the Coming Years

3.1.4. Growing Preferences for Natural Medicinal Products and Supplements

3.1.5. Changing Retail landscape

3.1.6. Globalization Impacting Lifestyles

3.1.7. Others

3.2. Product Innovation Trends

3.3. Evolution of OTC Healthcare Industry

3.4. Winning Themes

3.4.1. New Product Innovations- Clinical Evidence Supporting Their Claims

3.4.2. Effective Marketing- Key Active Ingredients

4. Risk and Opportunities in The Market

4.1. Associated Risk

4.1.1. Regulatory Landscape Associated Risk

4.1.2. Standard & Certification Risk

4.2. Opportunities

4.2.1. Niche Within The Existing Product Line

4.2.2. Opportunities In New Product Categories

4.2.3. Latent Opportunities In Established Market

4.3. Key Regulations & Industrial Standards

4.3.1. Rules & Regulations By Countries

4.3.2. Regulations With Respect To Imports

5. Impact of Covid-19 on The Market

5.1. Covid-19 The Situation Now

5.2. The Effects of National Lockdown in Various Countries

5.3. Scenarios For The Economic Impact of The Covid-19 Crisis

5.4. Industries Affected By Coronavirus Outbreak Worldwide

5.5. Projected Recovery for Hardest Hit Sectors

5.6. Coronavirus Impact on The World of Work

5.7. Impact of Covid-19 on Manufacturing Industry

5.8. Manufacturing Purchasing Managers Index, 2020

5.9. Impact of Covid-19 on Supply Chain Worldwide

5.10. Planning & Managing During Covid-19 Pandemic

5.11. Upcoming Pointers Business Leaders Should Focus On

6. Impact of Covid-19 on The OTC Consumer Healthcare Market

6.1. Impact of Covid-19 on the Industry

6.2. Covid-19 Impact v/s Value of OTC Consumer Healthcare Market, by Country 2020

6.3. OTC Consumer Healthcare Sales Projection, Q1-Q4 2020 During Covid-19 Pandemic

6.4. Pre Covid-19 Market Forecast v/s Post covid-19 Market Forecast

7. Covid-19 Impact on Retail Industry

7.1. Coronavirus Impact Matrix

7.2. Sales Increased Dramatically Across Most Categories; Paper Products, Home Care, and Personal Care Products Spiked in all Countries

7.3. Global Consumers Impact – Winning and Losing Segment Spending

7.4. Consumer Sentiment Reflects Fear of the Virus and of Recession

8. Global OTC Consumer Healthcare Market Demand Analysis 2015-2019 and Forecast, 2020-2030

8.1. Historical Market Volume (Mn Tons) Analysis, 2015-2019

8.2. Current and Future Market Volume (Mn Tons) Projections, 2020-2030

8.3. Y-o-Y Growth Trend Analysis

9. Global OTC Consumer Healthcare Market – Pricing Analysis

9.1. Regional Pricing Analysis By Product

9.2. Pricing Break-up

9.2.1. Manufacturer Level Pricing

9.2.2. Distributor Level Pricing

9.3. Global Average Pricing Analysis Benchmark

10. Global OTC Consumer Healthcare Market Demand (in Value or Size in US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030

10.1. Historical Market Value (US$ Mn) Analysis, 2015-2019

10.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030

10.2.1. Y-o-Y Growth Trend Analysis

10.2.2. Absolute $ Opportunity Analysis

11. Market Background

11.1. OTC Consumer Healthcare Products Industry

11.1.1. Prescribed vs OTC Healthcare Products Consumption Analysis

11.1.2. Top Global Player In Industry

11.1.3. Per Capita Spending on OTC Products

11.1.4. Penetration of OTC Consumer Healthcare Products in the Global Market

11.2. Macro-Economic Factors

11.2.1. Global GDP Growth Outlook

11.2.2. GDP Growth Rate Analysis

11.2.3. Global Industry Value Added

11.2.4. Global E-Commerce Industry Outlook

11.2.5. Per Capital Spending Outlook

11.2.6. Urbanization Growth Outlook

11.2.7. Global Healthcare Industry Outlook

11.3. Industry Value and Supply Chain Analysis

11.3.1. Profit Margin Analysis at each sales point

11.3.2. List & role of key participants

11.3.2.1. Manufacturers

11.3.2.2. Distributors/Retailers

11.3.2.3. List of Private Label Brands

11.4. Forecast Factors – Relevance & Impact

11.4.1. Top Companies Historical Growth

11.4.2. Global Pharmaceutical Industry Outlook

11.4.3. Global Consumer Price Index Outlook

11.4.4. Manufacturing Sector Gross Value Added

11.4.5. Global Retail Sales Outlook

11.5. Consumer Sentiment Analysis

11.5.1. Which Specific Brand Is Preferred By The Consumers And Why?

11.5.2. Factors Influencing Market Behaviour

11.5.3. Which Mode Of Advertisement Does Vendors Prefer?

11.5.4. What Are The Key Challenges Associated With The Market Suppliers?

11.5.5. Others

11.6. PESTLE Analysis of OTC Consumer Healthcare Market

11.7. Investment Feasibility Matrix of OTC Consumer Healthcare Market

11.8. Porter’s Five Force

11.9. Product Development and Launches

11.10. Market Dynamics

11.10.1. Drivers

11.10.2. Restraints

11.10.3. Opportunity Analysis

12. Global OTC Consumer Healthcare Market Analysis 2015-2019 and Forecast 2020-2030, by Product

12.1. Introduction / Key Findings

12.2. Historical Market Size (US$ Mn) and Volume (Mn Tons) Analysis By Product, 2015 – 2019

12.3. Current and Future Market Size (US$ Mn) and Volume (Mn Tons) Analysis and Forecast By Product, 2020 – 2030

12.3.1. OTC Pharmaceutical

12.3.1.1. Eye Care

12.3.1.2. Oral Health Care

12.3.1.3. Medicated Skin Care

12.3.1.4. Wound Care

12.3.1.5. Digestive Remedies

12.3.1.6. Sleeping Aids

12.3.1.7. Emergency Contraceptives

12.3.1.8. Intimate Care

12.3.1.9. Hair Care

12.3.1.10. Cough Cold & Allergy Remedies

12.3.1.11. Analgesics

12.3.1.12. Dermatological

12.3.2. Dietary Supplements

12.3.2.1. Nutrition

12.3.2.2. Vitamins

12.3.2.3. Minerals

12.3.2.4. Proteins

12.3.2.5. Others

12.4. Market Attractiveness Analysis By Product

13. Global OTC Consumer Healthcare Market Analysis 2015-2019 and Forecast 2020-2030, by End-user

13.1. Introduction / Key Findings

13.2. Historical Market Size (US$ Mn) and Volume (Mn Tons) Analysis By End-user, 2015 – 2019

13.3. Current and Future Market Size (US$ Mn) and Volume (Mn Tons) Analysis and Forecast By End-user, 2020 – 2030

13.3.1. 12-19 Years

13.3.2. Male

13.3.3. Female

13.3.4. Kids

13.4. Market Attractiveness Analysis By End-user

14. Global OTC Consumer Healthcare Market Analysis 2015-2019 and Forecast 2020-2030, by Form Type

14.1. Introduction / Key Findings

14.2. Historical Market Size (US$ Mn) and Volume (Mn Tons) Analysis By Form Type, 2015 – 2019

14.3. Current and Future Market Size (US$ Mn) and Volume (Mn Tons) Analysis and Forecast By Form Type, 2020 – 2030

14.3.1. Tablets

14.3.2. Powders

14.3.3. Liquids

14.3.4. Others

14.4. Market Attractiveness Analysis By Form Type

15. Global OTC Consumer Healthcare Market Analysis 2015-2019 and Forecast 2020-2030, by Sales Channel

15.1. Introduction / Key Findings

15.2. Historical Market Size (US$ Mn) and Volume (Mn Tons) Analysis By Sales Channel, 2015 – 2019

15.3. Current and Future Market Size (US$ Mn) and Volume (Mn Tons) Analysis and Forecast By Sales Channel, 2020 – 2030

15.3.1. Wholesalers & Distributors

15.3.2. Pharmacy or Drug Stores

15.3.3. Speciality Stores

15.3.4. Online Retailers

15.3.5. Hypermarkets/Supermarkets

15.3.6. Other Sales Channel

15.4. Market Attractiveness Analysis By Sales Channel

16. Global OTC Consumer Healthcare Market Analysis 2015-2019 and Forecast 2020-2030, by Region

16.1. Introduction

16.2. Historical Market Size (US$ Mn) and Volume (Mn Tons) Analysis By Region, 2015 – 2019

16.3. Current Market Size (US$ Mn) and Volume (Mn Tons) Analysis and Forecast By Region, 2020 – 2030

16.3.1. North America

16.3.2. Europe

16.3.3. Middle East and Africa (MEA)

16.3.4. East Asia

16.3.5. South Asia

16.3.6. Oceania

16.3.7. Latin America

16.4. Market Attractiveness Analysis By Region

17. North America OTC Consumer Healthcare Market Analysis 2015-2019 and Forecast 2020-2030

17.1. Introduction

17.2. Pricing Analysis

17.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019

17.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020 – 2030

17.4.1. By Country

17.4.1.1. U.S.

17.4.1.2. Canada

17.4.2. By Product

17.4.3. By End-user

17.4.4. By Form Type

17.4.5. By Sales Channel

17.5. Market Attractiveness Analysis

17.5.1. By Country

17.5.2. By Product

17.5.3. By End-user

17.5.4. By Form Type

17.5.5. By Sales Channel

17.6. Market Trends

17.7. Key Market Participants – Intensity Mapping

17.8. Drivers and Restraints – Impact Analysis

18. Latin America OTC Consumer Healthcare Market Analysis 2015-2019 and Forecast 2020-2030

18.1. Introduction

18.2. Pricing Analysis

18.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019

18.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020 – 2030

18.4.1. By Country

18.4.1.1. Brazil

18.4.1.2. Mexico

18.4.1.3. Rest of Latin America

18.4.2. By Product

18.4.3. By End-user

18.4.4. By Form Type

18.4.5. By Sales Channel

18.5. Market Attractiveness Analysis

18.5.1. By Country

18.5.2. By Product

18.5.3. By End-user

18.5.4. By Form Type

18.5.5. By Sales Channel

18.6. Market Trends

18.7. Key Market Participants – Intensity Mapping

18.8. Drivers and Restraints – Impact Analysis

19. Europe OTC Consumer Healthcare Market Analysis 2015-2019 and Forecast 2020-2030

19.1. Introduction

19.2. Pricing Analysis

19.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019

19.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020 – 2030

19.4.1. By Country

19.4.1.1. Germany

19.4.1.2. U.K.

19.4.1.3. Spain

19.4.1.4. France

19.4.1.5. Italy

19.4.1.6. Rest Of Europe

19.4.1.7. Rest of Europe

19.4.2. By Product

19.4.3. By End-user

19.4.4. By Form Type

19.4.5. By Sales Channel

19.5. Market Attractiveness Analysis

19.5.1. By Country

19.5.2. By Product

19.5.3. By End-user

19.5.4. By Form Type

19.5.5. By Sales Channel

19.6. Market Trends

19.7. Key Market Participants – Intensity Mapping

19.8. Drivers and Restraints – Impact Analysis

20. South Asia OTC Consumer Healthcare Market Analysis 2015-2019 and Forecast 2020-2030

20.1. Introduction

20.2. Pricing Analysis

20.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019

20.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020 – 2030

20.4.1. By Country

20.4.1.1. India

20.4.1.2. Thailand

20.4.1.3. Malaysia

20.4.1.4. Indonesia

20.4.1.5. Rest of South Asia

20.4.2. By Product

20.4.3. By End-user

20.4.4. By Form Type

20.4.5. By Sales Channel

20.5. Market Attractiveness Analysis

20.5.1. By Country

20.5.2. By Product

20.5.3. By End-user

20.5.4. By Form Type

20.5.5. By Sales Channel

20.6. Market Trends

20.7. Key Market Participants – Intensity Mapping

20.8. Drivers and Restraints – Impact Analysis

21. East Asia OTC Consumer Healthcare Market Analysis 2015-2019 and Forecast 2020-2030

21.1. Introduction

21.2. Pricing Analysis

21.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019

21.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020 – 2030

21.4.1. By Country

21.4.1.1. China

21.4.1.2. Japan

21.4.1.3. South Korea

21.4.2. By Product

21.4.3. By End-user

21.4.4. By Form Type

21.4.5. By Sales Channel

21.5. Market Attractiveness Analysis

21.5.1. By Country

21.5.2. By Product

21.5.3. By End-user

21.5.4. By Form Type

21.5.5. By Sales Channel

21.6. Market Trends

21.7. Key Market Participants – Intensity Mapping

21.8. Drivers and Restraints – Impact Analysis

22. Oceania OTC Consumer Healthcare Market Analysis 2015-2019 and Forecast 2020-2030

22.1. Introduction

22.2. Pricing Analysis

22.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019

22.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020 – 2030

22.4.1. By Country

22.4.1.1. Australia

22.4.1.2. New Zealand

22.4.2. By Product

22.4.3. By End-user

22.4.4. By Form Type

22.4.5. By Sales Channel

22.5. Market Attractiveness Analysis

22.5.1. By Country

22.5.2. By Product

22.5.3. By End-user

22.5.4. By Form Type

22.5.5. By Sales Channel

22.6. Market Trends

22.7. Key Market Participants – Intensity Mapping

22.8. Drivers and Restraints – Impact Analysis

23. Middle East and Africa OTC Consumer Healthcare Market Analysis 2015-2019 and Forecast 2020-2030

23.1. Introduction

23.2. Pricing Analysis

23.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019

23.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020 – 2030

23.4.1. By Country

23.4.1.1. GCC Countries

23.4.1.2. Northern Africa

23.4.1.3. South Africa

23.4.1.4. Rest of MEA

23.4.2. By Product

23.4.3. By End-user

23.4.4. By Form Type

23.4.5. By Sales Channel

23.5. Market Attractiveness Analysis

23.5.1. By Country

23.5.2. By Product

23.5.3. By End-user

23.5.4. By Form Type

23.5.5. By Sales Channel

23.6. Market Trends

23.7. Key Market Participants – Intensity Mapping

23.8. Drivers and Restraints – Impact Analysis

24. Market Structure Analysis

24.1. Market Analysis by Tier of Companies (OTC Consumer Healthcare)

24.2. Market Concentration

24.3. Market Share Analysis of Top Players

24.4. Market Presence Analysis

24.4.1. By Regional footprint of Players

24.4.2. Product foot print by Players

24.4.3. Channel Foot Print by Players

25. Competition Analysis

25.1. Competition Dashboard

25.2. Pricing Analysis by Competition

25.3. Competition Benchmarking

25.4. Competition Deep Dive

25.4.1. Sun Pharmaceutical Industries Limited

25.4.1.1. Overview

25.4.1.2. Product Portfolio

25.4.1.3. Profitability by Market Segments (Product/Channel/Region)

25.4.1.4. Sales Footprint

25.4.1.5. Strategy Overview

25.4.1.5.1. Marketing Strategy

25.4.1.5.2. Product Strategy

25.4.1.5.3. Channel Strategy

25.4.2. Glenmark Pharmaceuticals Ltd.

25.4.2.1. Overview

25.4.2.2. Product Portfolio

25.4.2.3. Profitability by Market Segments (Product/Channel/Region)

25.4.2.4. Sales Footprint

25.4.2.5. Strategy Overview

25.4.2.5.1. Marketing Strategy

25.4.2.5.2. Product Strategy

25.4.2.5.3. Channel Strategy

25.4.3. Johnson & Johnson Private Ltd, Pfizer, Inc.

25.4.3.1. Overview

25.4.3.2. Product Portfolio

25.4.3.3. Profitability by Market Segments (Product/Channel/Region)

25.4.3.4. Sales Footprint

25.4.3.5. Strategy Overview

25.4.3.5.1. Marketing Strategy

25.4.3.5.2. Product Strategy

25.4.3.5.3. Channel Strategy

25.4.4. American Health Corporation

25.4.4.1. Overview

25.4.4.2. Product Portfolio

25.4.4.3. Profitability by Market Segments (Product/Channel/Region)

25.4.4.4. Sales Footprint

25.4.4.5. Strategy Overview

25.4.4.5.1. Marketing Strategy

25.4.4.5.2. Product Strategy

25.4.4.5.3. Channel Strategy

25.4.5. Abbott Laboratories Inc.

25.4.5.1. Overview

25.4.5.2. Product Portfolio

25.4.5.3. Profitability by Market Segments (Product/Channel/Region)

25.4.5.4. Sales Footprint

25.4.5.5. Strategy Overview

25.4.5.5.1. Marketing Strategy

25.4.5.5.2. Product Strategy

25.4.5.5.3. Channel Strategy

25.4.6. GlaxoSmithKline plc

25.4.6.1. Overview

25.4.6.2. Product Portfolio

25.4.6.3. Profitability by Market Segments (Product/Channel/Region)

25.4.6.4. Sales Footprint

25.4.6.5. Strategy Overview

25.4.6.5.1. Marketing Strategy

25.4.6.5.2. Product Strategy

25.4.6.5.3. Channel Strategy

25.4.7. Sanofi S.A.

25.4.7.1. Overview

25.4.7.2. Product Portfolio

25.4.7.3. Profitability by Market Segments (Product/Channel/Region)

25.4.7.4. Sales Footprint

25.4.7.5. Strategy Overview

25.4.7.5.1. Marketing Strategy

25.4.7.5.2. Product Strategy

25.4.7.5.3. Channel Strategy

25.4.8. Piramal Enterprises Ltd.

25.4.8.1. Overview

25.4.8.2. Product Portfolio

25.4.8.3. Profitability by Market Segments (Product/Channel/Region)

25.4.8.4. Sales Footprint

25.4.8.5. Strategy Overview

25.4.8.5.1. Marketing Strategy

25.4.8.5.2. Product Strategy

25.4.8.5.3. Channel Strategy

25.4.9. Boehringer Ingelheim GmbH

25.4.9.1. Overview

25.4.9.2. Product Portfolio

25.4.9.3. Profitability by Market Segments (Product/Channel/Region)

25.4.9.4. Sales Footprint

25.4.9.5. Strategy Overview

25.4.9.5.1. Marketing Strategy

25.4.9.5.2. Product Strategy

25.4.9.5.3. Channel Strategy

25.4.10. Bayer AG

25.4.10.1. Overview

25.4.10.2. Product Portfolio

25.4.10.3. Profitability by Market Segments (Product/Channel/Region)

25.4.10.4. Sales Footprint

25.4.10.5. Strategy Overview

25.4.10.5.1. Marketing Strategy

25.4.10.5.2. Product Strategy

25.4.10.5.3. Channel Strategy

25.4.11. Teva Pharmaceutical Industries Ltd.

25.4.11.1. Overview

25.4.11.2. Product Portfolio

25.4.11.3. Profitability by Market Segments (Product/Channel/Region)

25.4.11.4. Sales Footprint

25.4.11.5. Strategy Overview

25.4.11.5.1. Marketing Strategy

25.4.11.5.2. Product Strategy

25.4.11.5.3. Channel Strategy

25.4.12. Ipsen SA, BASF SE

25.4.12.1. Overview

25.4.12.2. Product Portfolio

25.4.12.3. Profitability by Market Segments (Product/Channel/Region)

25.4.12.4. Sales Footprint

25.4.12.5. Strategy Overview

25.4.12.5.1. Marketing Strategy

25.4.12.5.2. Product Strategy

25.4.12.5.3. Channel Strategy

25.4.13. Koninklijke DSM N.V.

25.4.13.1. Overview

25.4.13.2. Product Portfolio

25.4.13.3. Profitability by Market Segments (Product/Channel/Region)

25.4.13.4. Sales Footprint

25.4.13.5. Strategy Overview

25.4.13.5.1. Marketing Strategy

25.4.13.5.2. Product Strategy

25.4.13.5.3. Channel Strategy

25.4.14. Reckitt Benckiser LLC.

25.4.14.1. Overview

25.4.14.2. Product Portfolio

25.4.14.3. Profitability by Market Segments (Product/Channel/Region)

25.4.14.4. Sales Footprint

25.4.14.5. Strategy Overview

25.4.14.5.1. Marketing Strategy

25.4.14.5.2. Product Strategy

25.4.14.5.3. Channel Strategy

25.4.15. Lonza Group Ltd.

25.4.15.1. Overview

25.4.15.2. Product Portfolio

25.4.15.3. Profitability by Market Segments (Product/Channel/Region)

25.4.15.4. Sales Footprint

25.4.15.5. Strategy Overview

25.4.15.5.1. Marketing Strategy

25.4.15.5.2. Product Strategy

25.4.15.5.3. Channel Strategy

25.4.16. Other Players (as per request)

25.4.16.1. Overview

25.4.16.2. Product Portfolio

25.4.16.3. Profitability by Market Segments (Product/Channel/Region)

25.4.16.4. Sales Footprint

25.4.16.5. Strategy Overview

25.4.16.5.1. Marketing Strategy

25.4.16.5.2. Product Strategy

25.4.16.5.3. Channel Strategy

26. Assumptions and Acronyms Used

27. Research Methodology

List Of Tables

Table 1: Global OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Product, 2015–2030

Table 2: Global OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Product, 2015–2030

Table 3: Global OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By End-User, 2015–2030

Table 4: Global OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By End-User, 2015–2030

Table 5: Global OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Form, 2015–2030

Table 6: Global OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Form, 2015–2030

Table 7: Global OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Sales Channel, 2015–2030

Table 8: Global OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Sales Channel, 2015–2030

Table 9: Global OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Region, 2015–2030

Table 10: Global OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Region, 2015–2030

Table 11: North America OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Country, 2015–2030

Table 12: North America OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Country, 2015–2030

Table 13: North America OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Product, 2015–2030

Table 14: North America OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Product, 2015–2030

Table 15: North America OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By End-User, 2015–2030

Table 16: North America OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By End-User, 2015–2030

Table 17: North America OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Form, 2015–2030

Table 18: North America OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Form, 2015–2030

Table 19: North America OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Sales Channel, 2015–2030

Table 20: North America OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Sales Channel, 2015–2030

Table 21: Latin America OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Country, 2015–2030

Table 22: Latin America OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Country, 2015–2030

Table 23: Latin America OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Product, 2015–2030

Table 24: Latin America OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Product, 2015–2030

Table 25: Latin America OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By End-User, 2015–2030

Table 26: Latin America OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By End-User, 2015–2030

Table 27: Latin America OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Form, 2015–2030

Table 28: Latin America OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Form, 2015–2030

Table 29: Latin America OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Sales Channel, 2015–2030

Table 30: Latin America OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Sales Channel, 2015–2030

Table 31: Europe OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Country, 2015–2030

Table 32: Europe OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Country, 2015–2030

Table 33: Europe OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Product, 2015–2030

Table 34: Europe OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Product, 2015–2030

Table 35: Europe OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By End-User, 2015–2030

Table 36: Europe OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By End-User, 2015–2030

Table 37: Europe OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Form, 2015–2030

Table 38: Europe OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Form, 2015–2030

Table 39: Europe OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Sales Channel, 2015–2030

Table 40: Europe OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Sales Channel, 2015–2030

Table 41: South Asia OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Country, 2015–2030

Table 42: South Asia OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Country, 2015–2030

Table 43: South Asia OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Product, 2015–2030

Table 44: South Asia OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Product, 2015–2030

Table 45: South Asia OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By End-User, 2015–2030

Table 46: South Asia OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By End-User, 2015–2030

Table 47: South Asia OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Form, 2015–2030

Table 48: South Asia OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Form, 2015–2030

Table 49: South Asia OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Sales Channel, 2015–2030

Table 50: South Asia OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Sales Channel, 2015–2030

Table 51: East Asia OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Country, 2015–2030

Table 52: East Asia OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Country, 2015–2030

Table 53: East Asia OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Product, 2015–2030

Table 54: East Asia OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Product, 2015–2030

Table 55: East Asia OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By End-User, 2015–2030

Table 56: East Asia OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By End-User, 2015–2030

Table 57: East Asia OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Form, 2015–2030

Table 58: East Asia OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Form, 2015–2030

Table 59: East Asia OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Sales Channel, 2015–2030

Table 60: East Asia OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Sales Channel, 2015–2030

Table 61: Oceania OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Country, 2015–2030

Table 62: Oceania OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Country, 2015–2030

Table 63: Oceania OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Product, 2015–2030

Table 64: Oceania OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Product, 2015–2030

Table 65: Oceania OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By End-User, 2015–2030

Table 66: Oceania OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By End-User, 2015–2030

Table 67: Oceania OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Form, 2015–2030

Table 68: Oceania OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Form, 2015–2030

Table 69: Oceania OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Sales Channel, 2015–2030

Table 70: Oceania OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Sales Channel, 2015–2030

Table 71: MEA OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Country, 2015–2030

Table 72: MEA OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Country, 2015–2030

Table 73: MEA OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Product, 2015–2030

Table 74: MEA OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Product, 2015–2030

Table 75: MEA OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By End-User, 2015–2030

Table 76: MEA OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By End-User, 2015–2030

Table 77: MEA OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Form, 2015–2030

Table 78: MEA OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Form, 2015–2030

Table 79: MEA OTC Consumer Healthcare Market Value (US$ Mn) Analysis, By Sales Channel, 2015–2030

Table 80: MEA OTC Consumer Healthcare Market Volume (Mn Tons) Analysis, By Sales Channel, 2015–2030